Immunohistochemical Panel of Undifferentiated Orbital Metastatic Carcinomas

REFERENCES

• Abbruzzese J L, Abbruzzese M C, Lenzi R, Hess K R, Raber M N. Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 1995; 13: 2094–2103
   PubMed Web of Science ®Google Scholar
• Amemiya T, Hayashida H, Dake Y. Metastatic orbital tumors in Japan: a review of the literature. Ophthalmic Epidemiol 2002; 9: 35–47
   PubMed Web of Science ®Google Scholar
• Barbat V, Morin Y, Metge F, Hamard H. [Hepatocellular carcinoma: a case revealed by metastatic orbital tumor]. Rev Med Interne 2000; 21: 86–90
   PubMedGoogle Scholar
• Bloch R S, Gartner S. The incidence of ocular metastatic carcinoma. Arch Ophthalmol 1971; 85: 673–675
   PubMedGoogle Scholar
• Bomanji J, Glaholm J, Hungerford J L, Mather S J, Granowska M, Britton K E, et al. Radioimmunoscintigraphy of orbital metastases from ovarian carcinoma. Clin Nucl Med 1990; 15: 825–827
   PubMedGoogle Scholar
• Brown R W, Campagna L B, Dunn J K, Cagle P T. Immunohistochemical identification of tumor markers in metastatic adenocarcinoma. A diagnostic adjunct in the determination of primary site. Am J Clin Pathol 1997; 107: 12–19
   PubMed Web of Science ®Google Scholar
• Buenechea R, Garatea J, Castro-Forns M, Bassas C. Parotid gland metastases from orbital tumors: report of two cases. J Oral Maxillofac Surg 1993; 51: 570–574
   PubMedGoogle Scholar
• Burnier M N, Jr., McLean I W, Gamel J W. Immunohistochemical evaluation of uveal melanocytic tumors. Expression of HMB-45, S-100 protein, and neuron-specific enolase. Cancer 1991; 68: 809–814
   PubMedGoogle Scholar
• Char D H, Miller T, Kroll S. Orbital metastases: diagnosis and course. Br J Ophthalmol 1997; 81: 386–390
   PubMed Web of Science ®Google Scholar
• Chu P, Wu E, Weiss L M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13: 962–972
   PubMed Web of Science ®Google Scholar
• Chu P G, Weiss L M. Keratin expression in human tissues and neoplasms. Histopathology 2002; 40: 403–439
   PubMed Web of Science ®Google Scholar
• D'Amico T A, Aloia T A, Moore M B, Conlon D H, Herndon J E, 2nd, Kinch M S, et al. Predicting the sites of metastases from lung cancer using molecular biologic markers. Ann Thorac Surg 2001; 72: 1144–1148
   PubMed Web of Science ®Google Scholar
• Daumerie C, De Potter P, Godfraind C, Rahier J, Jamar F, Squifflet J P. Orbital metastasis as primary manifestation of thyroid carcinoma. Thyroid 2000; 10: 189–192
   PubMedGoogle Scholar
• de Almeida P C, Pestana C B. Immunohistochemical markers in the identification of metastatic breast cancer. Breast Cancer Res Treat 1992; 21: 201–210
   PubMedGoogle Scholar
• Font R L, Ferry A P. Carcinoma metastatic to the eye and orbit III. A clinicopathologic study of 28 cases metastatic to the orbit. Cancer 1976; 38: 1326–1335
   PubMed Web of Science ®Google Scholar
• Genega E M, Hutchinson B, Reuter V E, Gaudin P B. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod Pathol 2000; 13: 1186–1191
   PubMedGoogle Scholar
• Ghosh L, Dahut W, Kakar S, Posadas E M, Torres C G, Cancel-Santiago R, et al. Management of patients with metastatic cancer of unknown primary. Curr Probl Surg 2005; 42: 12–66
   PubMedGoogle Scholar
• Giordana M T, Cordera S, Boghi A. Cerebral metastases as first symptom of cancer: a clinico-pathologic study. J Neurooncol 2000; 50: 265–273
   PubMedGoogle Scholar
• Goldberg R A, Rootman J. Clinical characteristics of metastatic orbital tumors. Ophthalmology 1990; 97: 620–624
   PubMed Web of Science ®Google Scholar
• Han J H, Kang Y, Shin H C, Kim H S, Kang Y M, Kim Y B, et al. Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma. Arch Pathol Lab Med 2003; 127: 1330–1334
   PubMedGoogle Scholar
• Howard G M, Jakobiec F A, Trokel S L, Iwamoto T, Jones I S. Pulsating metastatic tumor of the orbit. Am J Ophthalmol 1978; 85: 767–771
   PubMedGoogle Scholar
• Inai H, Shimazui T, Yamamoto T, Yamauchi A, Uchida K, Takeshima H, et al. [A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9]. Hinyokika Kiyo 2001; 47: 583–586
   PubMedGoogle Scholar
• Kennedy R E. An evaluation of 820 orbital cases. Trans Am Ophthalmol Soc 1984; 82: 134–157
   PubMedGoogle Scholar
• Lagendijk J H, Mullink H, van Diest P J, Meijer G A, Meijer C J. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. J Clin Pathol 1999; 52: 283–290
   PubMed Web of Science ®Google Scholar
• Matthews P, Ellis I O. Use of immunocytochemistry in the diagnosis of metastatic carcinoma. Ann Med 1996; 28: 297–300
   PubMed Web of Science ®Google Scholar
• Mintzer D M, Warhol M, Martin A M, Greene G. Cancer of unknown primary: changing approaches. A multidisciplinary case presentation from the Joan Karnell cancer center of pennsylvania hospital. Oncologist 2004; 9: 330–338
   PubMedGoogle Scholar
• Narang N K, Bhandari V M, Mathur D S, Duggal N. Bilateral proptosis due to carcinoma of pancreas. J Assoc Physicians India 1973; 21: 331–333
   PubMedGoogle Scholar
• Pavlidis N, Briasoulis E, Hainsworth J, Greco F A. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003; 39: 1990–2005
   PubMed Web of Science ®Google Scholar
• Reifler D M, Kini S R, Liu D, Littleton R H. Orbital metastasis from prostatic carcinoma. Identification by immunocytology. Arch Ophthalmol 1984; 102: 292–295
   PubMedGoogle Scholar
• Rodriguez S L, Kostick D A, Hered R W, Joyce M J. Primary embryonal carcinoma of the orbit in a 10-month-old female: a seven-year follow-up. Am J Ophthalmol 2005; 139: 380–381
   PubMedGoogle Scholar
• Scharf Y, Ben Arieh Y, Gellei B. Orbital metastases from extra-adrenal pheochromocytoma. Am J Ophthalmol 1970; 69: 638–640
   PubMedGoogle Scholar
• Sheahan K, O'Keane J C, Abramowitz A, Carlson J A, Burke B, Gottlieb L S, et al. Metastatic adenocarcinoma of an unknown primary site. A comparison of the relative contributions of morphology, minimal essential clinical data and CEA immunostaining status. Am J Clin Pathol 1993; 99: 729–735
   PubMedGoogle Scholar
• Shields J A, Bakewell B, Augsburger J J, Flanagan J C. Classification and incidence of space-occupying lesions of the orbit. A survey of 645 biopsies. Arch Ophthalmol 1984; 102: 1606–1611
   PubMed Web of Science ®Google Scholar
• Shields J A, Shields C L, Brotman H K, Carvalho C, Perez N, Eagle R C, Jr. Cancer metastatic to the orbit: the 2000 Robert M. Curts Lecture. Ophthal Plast Reconstr Surg 2001; 17: 346–354
   PubMed Web of Science ®Google Scholar
• Shields J A, Shields C L, Scartozzi R. Survey of 1264 patients with orbital tumors and simulating lesions: The 2002 Montgomery Lecture, part 1. Ophthalmology 2004; 111: 997–1008
   PubMed Web of Science ®Google Scholar
• Smith S K, Brown V A, Dewar A E, Stockdill G, Cohen B, Maddy A H. Abnormalities in the expression of the leucocyte-common antigen in chronic lymphocytic leukaemia. Clin Exp Immunol 1985; 59: 55–63
   PubMedGoogle Scholar
• Tan J, Sidhu G, Greco M A, Ballard H, Wieczorek R. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets. Hum Pathol 1998; 29: 390–396
   PubMed Web of Science ®Google Scholar
• Thomas K M, Cumberworth V L, McEwan J. Orbital and skin metastases in a polymorphous low grade adenocarcinoma of the salivary gland. J Laryngol Otol 1995; 109: 1222–1225
   PubMedGoogle Scholar
• Varadhachary G R, Abbruzzese J L, Lenzi R. Diagnostic strategies for unknown primary cancer. Cancer 2004; 100: 1776–1785
   PubMed Web of Science ®Google Scholar
• Watson M A, Dintzis S, Darrow C M, Voss L E, Di Persio J, Jensen R, et al. Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 1999; 59: 3028–3031
   PubMed Web of Science ®Google Scholar